Stroke is a medical emergency requiring rapid diagnosis and hyperacute treatment often followed by complex long-term consequences that need to be tackled at different levels and at different times after onset, often for many years.
The NHS Long Term Plan (LTP) sets out ambitions to improve the quality of service and care for stroke patients and to reduce the loss of independent lives to stroke by early identification of at-risk patients, and the provision of support to patients to help them manage their condition. It aims to make specialist care and treatments available to more patients in a more timely and efficient manner, and further enhance the delivery of rehabilitation to improve their recovery.
Under this Phase 3 Funding Competition, three challenges have been identified via consultation with clinicians and other stakeholders working in provision of care across the spectrum and review of the James Lind Alliance Stroke Priority Setting Partnership for Stroke Research:
-
Early diagnosis
-
Rehabilitation
-
Life after stroke.
Emphasis should be placed on how the technology/innovation will address any challenges associated with health inequalities, such as demographic and geographic disparities, and it is expected that applicants provide details on how they will address these e.g. provide details on the care pathway the intervention will affect and how it can improve this.
The aim of the competition is to facilitate the collection of evidence in real-world settings and build on the value proposition required by commissioners and regulators to accelerate the uptake of the innovation into relevant health or social care settings.
The competition is open to any innovation (e.g., medical device, in-vitro diagnostic, digital health solutions and AI solutions, behavioural interventions, and service improvements) that meets the entry criteria and the challenges described in the Challenge brief.
Single organisations (contracts are executed with individual legal entities) based in the UK or EU from the private, public and third sectors, including companies (large corporates and small and medium enterprises), charities, universities, and NHS providers, given a strong commercial strategy is provided, are eligible to apply.
Organisations based outside the UK or EU with innovations in remit for this call can apply as subcontractors of a lead UK/EU based organisation or via a UK or EU subsidiary.
Collaborations are encouraged in the form of subcontracted services as appropriate.
The upper funding limit of SBRI Healthcare Phase 3 competitions is £500,000 excluding VAT.
Please ensure you are registered on the Research Management System (RMS) in order to begin your application.
We advise that you register on the RMS 7 days in advance of the competition deadline in order to have your account approved on time.
Please read the guidance on the How to apply page - Phase 3 Guidance for Applicants, Portal Guidance, and the FAQs page.
Register for the launch webinar, Tues 23 July, 1-3pm. Sign up on Eventbrite